Combined LDL apheresis and hemodialysis in a patient with end-stage renal disease and accelerated coronary atherosclerosis.
The first long-term experience with lipid apheresis in a hemodialysis patient with refractory combined hyperlipidemia and coronary heart disease is described. Simultaneous treatment was performed once a week using two separate machines connected by parallel flow. Correction of hyperlipidemia was achieved, accompanied by inhibition of progressive coronary heart disease, enabling kidney transplantation.
Grützmacher
P
P
2nd Medical Clinic, Markus Hospital, Frankfurt/Main, Germany.
Vallbracht
C
C
Scheuermann
E
E
Kurz
P
P
Schoeppe
W
W
D000328:Adult; D001781:Blood Component Removal / Q000295:instrumentation; D008078:Cholesterol, LDL / Q000097:blood; D003131:Combined Modality Therapy; D003324:Coronary Artery Disease / Q000097:blood* / Q000628:therapy*; D004562:Electrocardiography; D006801:Humans; D007676:Kidney Failure, Chronic / Q000097:blood* / Q000628:therapy*; D008077:Lipoproteins, LDL / Q000097:blood*; D008297:Male; D006435:Renal Dialysis / Q000295:instrumentation
D008078:Cholesterol, LDL; D008077:Lipoproteins, LDL